Otsuka's experimental therapy for a potentially life-threatening kidney disease more than halved severe levels of protein in the urine of patients, intensifying the battle for an effective new ...

Otsuka's experimental drug reduced the levels of protein in urine by more than 50% in patients with a type of kidney disease, the Japan-based company said on Friday. The therapy, sibeprenlimab, ...

Otsuka's experimental drug for a type of kidney disease showed over 50% reduction in protein in patients' urine in a late-stage trial, the Japan-based company said on Friday. Patients treated with the ...

A study led by Cancer Center at Illinois (CCIL) member Jason Ridlon, associate professor of animal sciences in the College of ...